These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12061248)

  • 21. Bacterial adaptation and resistance to antiseptics, disinfectants and preservatives is not a new phenomenon.
    Russell AD
    J Hosp Infect; 2004 Jun; 57(2):97-104. PubMed ID: 15183238
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of intergeneric coaggregation among oral bacteria by cetylpyridinium chloride, chlorhexidine digluconate and octenidine dihydrochloride.
    Smith RN; Andersen RN; Kolenbrander PE
    J Periodontal Res; 1991 Sep; 26(5):422-8. PubMed ID: 1832455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of a chlorhexidine-containing mouthwash against subgingival bacteria.
    Wade WG; Addy M
    J Periodontol; 1989 Sep; 60(9):521-5. PubMed ID: 2795419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Taurolin as an oral rinse. I. Antimicrobial effects in vitro and in vivo.
    Reynolds S; Moran J; Addy M; Wade WG; Newcombe R
    Clin Prev Dent; 1991; 13(2):13-7. PubMed ID: 1860285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chlorhexidine gluconate mouth wash on the plaque microflora in children using intra oral appliances.
    Amitha H; Munshi AK
    J Clin Pediatr Dent; 1995; 20(1):23-9. PubMed ID: 8634191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in chlorhexidine minimal inhibitory concentration of Acinetobacter baumannii clinical isolates after implementation of advanced source control.
    Apisarnthanarak A; Yang Hsu L; Lim TP; Mundy LM
    Infect Control Hosp Epidemiol; 2014 Jan; 35(1):98-9. PubMed ID: 24334810
    [No Abstract]   [Full Text] [Related]  

  • 27. Differences in efficacy of two commercial 0.2% chlorhexidine mouthrinse solutions: a 4-day plaque re-growth study.
    Arweiler NB; Boehnke N; Sculean A; Hellwig E; Auschill TM
    J Clin Periodontol; 2006 May; 33(5):334-9. PubMed ID: 16634954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracanal medicaments: evaluation of the antibacterial effects of chlorhexidine, metronidazole, and calcium hydroxide associated with three vehicles.
    Siqueira JF; de Uzeda M
    J Endod; 1997 Mar; 23(3):167-9. PubMed ID: 9594757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiological aspects of an in situ model to study effects of antimicrobial agents on dental plaque ecology.
    Giertsen E; Guggenheim B; Thurnheer T; Gmür R
    Eur J Oral Sci; 2000 Oct; 108(5):403-11. PubMed ID: 11037756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the contribution of anaerobic microflora of the tongue to oral malodor.
    De Boever EH; Loesche WJ
    J Am Dent Assoc; 1995 Oct; 126(10):1384-93. PubMed ID: 7594010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of chlorhexidine gluconate douche on normal vaginal flora.
    Shubair M; Stanek R; White S; Larsen B
    Gynecol Obstet Invest; 1992; 34(4):229-33. PubMed ID: 1487182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro bacteriocidal activity of 5 oral antiseptics against the principal microorganisms implicated in oral disease].
    Luc J; Roques C; Frayret MN; Michel G; Ducani M; Vandermander J
    J Parodontol; 1991 Nov; 10(4):381-7. PubMed ID: 1811047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cationic compounds with activity against multidrug-resistant bacteria: interest of a new compound compared with two older antiseptics, hexamidine and chlorhexidine.
    Grare M; Dibama HM; Lafosse S; Ribon A; Mourer M; Regnouf-de-Vains JB; Finance C; Duval RE
    Clin Microbiol Infect; 2010 May; 16(5):432-8. PubMed ID: 19456831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Resistance of 700 gram-negative bacterial strains to antiseptics and antibiotics].
    Maris P
    Ann Rech Vet; 1991; 22(1):11-23. PubMed ID: 2042903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical response to 2 different therapeutic regimens to treat peri-implant mucositis.
    Porras R; Anderson GB; Caffesse R; Narendran S; Trejo PM
    J Periodontol; 2002 Oct; 73(10):1118-25. PubMed ID: 12416768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and microbiologic effects of subgingival controlled-release delivery of chlorhexidine chip in the treatment of periodontitis: a multicenter study.
    Paolantonio M; D'Angelo M; Grassi RF; Perinetti G; Piccolomini R; Pizzo G; Annunziata M; D'Archivio D; D'Ercole S; Nardi G; Guida L
    J Periodontol; 2008 Feb; 79(2):271-82. PubMed ID: 18251641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a controlled-release chlorhexidine chip on clinical and microbiological parameters and prostaglandin E2 levels in gingival crevicular fluid.
    Mizrak T; Güncü GN; Caglayan F; Balci TA; Aktar GS; Ipek F
    J Periodontol; 2006 Mar; 77(3):437-43. PubMed ID: 16512758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of sustained release doxycycline on the anaerobic flora and antibiotic-resistant patterns in subgingival plaque and saliva.
    Walker CB; Godowski KC; Borden L; Lennon J; Nangó S; Stone C; Garrett S
    J Periodontol; 2000 May; 71(5):768-74. PubMed ID: 10872958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of surface adsorption and staining reactions on the antimicrobial properties of some cationic antiseptic mouthwashes.
    Moran J; Addy M
    J Periodontol; 1984 May; 55(5):278-82. PubMed ID: 6376757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The minimum inhibitory concentration of oral antibacterial agents against cariogenic organisms.
    Botelho MG
    Microbios; 2000; 103(404):31-41. PubMed ID: 11034444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.